Therapeutic Implications of the Cancer Stem Cell Hypothesis

Overview

Journal Semin Radiat Oncol

Specialties Oncology
Radiology

Date 2009 Mar 3

PMID 19249645

Citations 68

Authors

Maximilian Diehn

Robert W Cho

Michael F Clarke

Affiliations

Soon will be listed here.

Abstract

A growing body of evidence indicates that subpopulations of cancer stem cells (CSCs) drive and maintain many types of human malignancies. These findings have important implications for the development and evaluation of oncologic therapies and present opportunities for potential gains in patient outcome. The existence of CSCs mandates careful analysis and comparison of normal tissue stem cells and CSCs to identify differences between the two cell types. The development of CSC-targeted treatments will face a number of potential hurdles, including normal stem cell toxicity and the acquisition of treatment resistance, which must be considered in order to maximize the chance that such therapies will be successful.

Citing Articles

The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.

Spallotta F, Illi B Biomedicines. 2024; 12(11).

PMID: 39595195 PMC: 11591585. DOI: 10.3390/biomedicines12112631.

Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine.

Rapanotti M, Cenci T, Scioli M, Cugini E, Anzillotti S, Savino L Biomedicines. 2024; 12(9).

PMID: 39335650 PMC: 11429165. DOI: 10.3390/biomedicines12092137.

Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?.

Pasqualetti F, Miniati M, Gonnelli A, Gadducci G, Giannini N, Palagini L Biology (Basel). 2023; 12(10).

PMID: 37887005 PMC: 10604498. DOI: 10.3390/biology12101295.

Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers.

Sharma T, Zhang Y, Zigrossi A, Cravatt B, Kastrati I Breast Cancer Res Treat. 2023; 201(3):561-570.

PMID: 37477798 DOI: 10.1007/s10549-023-07037-4.

The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme.

Cencioni C, Scagnoli F, Spallotta F, Nasi S, Illi B Int J Mol Sci. 2023; 24(4).

PMID: 36835628 PMC: 9966483. DOI: 10.3390/ijms24044217.

References

Fialkow P, Singer J, Adamson J, Vaidya K, Dow L, Ochs J . Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 1981; 57(6):1068-73. View

Marhaba R, Zoller M . CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol. 2004; 35(3):211-31. DOI: 10.1023/b:hijo.0000032354.94213.69. View

Jamieson C, Ailles L, Dylla S, Muijtjens M, Jones C, Zehnder J . Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004; 351(7):657-67. DOI: 10.1056/NEJMoa040258. View

Huff C, Matsui W, Smith B, Jones R . The paradox of response and survival in cancer therapeutics. Blood. 2005; 107(2):431-4. PMC: 1895602. DOI: 10.1182/blood-2005-06-2517. View

OBrien C, Pollett A, Gallinger S, Dick J . A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2006; 445(7123):106-10. DOI: 10.1038/nature05372. View

Korkaya H, Paulson A, Iovino F, Wicha M . HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene. 2008; 27(47):6120-30. PMC: 2602947. DOI: 10.1038/onc.2008.207. View

Honeth G, Bendahl P, Ringner M, Saal L, Gruvberger-Saal S, Lovgren K . The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008; 10(3):R53. PMC: 2481503. DOI: 10.1186/bcr2108. View

Dinh P, de Azambuja E, Cardoso F, Piccart-Gebhart M . Facts and controversies in the use of trastuzumab in the adjuvant setting. Nat Clin Pract Oncol. 2008; 5(11):645-54. DOI: 10.1038/ncponc1219. View

Jin L, Hope K, Zhai Q, Smadja-Joffe F, Dick J . Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12(10):1167-74. DOI: 10.1038/nm1483. View

10.

Hamburger A, Salmon S . Primary bioassay of human tumor stem cells. Science. 1977; 197(4302):461-3. DOI: 10.1126/science.560061. View

11.

Tsai Y, Lu Y, Nichols P, Zlotnikov G, Jones P, Smith H . Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res. 1996; 56(2):402-4. View

12.

Rocha Lima C, Green M, Rotche R, Miller Jr W, Jeffrey G, Cisar L . Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol. 2004; 22(18):3776-83. DOI: 10.1200/JCO.2004.12.082. View

13.

Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

14.

Dovey J, Zacharek S, Kim C, Lees J . Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci U S A. 2008; 105(33):11857-62. PMC: 2575250. DOI: 10.1073/pnas.0803574105. View

15.

Hart L, El-Deiry W . Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol. 2008; 26(17):2901-10. DOI: 10.1200/JCO.2008.16.9573. View

16.

Cho R, Wang X, Diehn M, Shedden K, Chen G, Sherlock G . Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells. 2007; 26(2):364-71. DOI: 10.1634/stemcells.2007-0440. View

17.

Park I, He Y, Lin F, Laerum O, Tian Q, Bumgarner R . Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002; 99(2):488-98. DOI: 10.1182/blood.v99.2.488. View

18.

Easterday M, Dougherty J, Jackson R, Ou J, Nakano I, Paucar A . Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations. Dev Biol. 2003; 264(2):309-22. DOI: 10.1016/j.ydbio.2003.09.003. View

19.

Piccirillo S, Reynolds B, Zanetti N, Lamorte G, Binda E, Broggi G . Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006; 444(7120):761-5. DOI: 10.1038/nature05349. View

20.

Li X, Lewis M, Huang J, Gutierrez C, Osborne C, Wu M . Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008; 100(9):672-9. DOI: 10.1093/jnci/djn123. View